- in 1995.
Valdecoxib was
manufactured and
marketed under the
brand name
Bextra by G. D.
Searle &
Company as an anti-inflammatory
arthritis drug. It was...
-
Pfizer pleaded guilty to the
illegal marketing of
arthritis drug
valdecoxib (
Bextra) and
agreed to a $2.3 billion settlement, the
largest health care fraud...
-
involved Eli Lilly's
antipsychotic Zyprexa, and the
other involved Bextra. In the
Bextra case, the
government also
charged Pfizer with
illegally marketing...
- on
August 9, 2007.
Retrieved August 15, 2007. "COX-2
Selective (includes
Bextra, Celebrex, and Vioxx)". U.S. Food and Drug Administration.
April 7, 2005...
-
antipsychotic Zyprexa, and the
other involved Bextra, an anti-inflammatory
medication used for arthritis. In the
Bextra case, the
government also
charged Pfizer...
- doi:10.1001/jama.296.13.jrv60015. PMID 16968832. "COX-2
Selective (includes
Bextra, Celebrex, and Vioxx) and Non-Selective Non-Steroidal Anti-Inflammatory...
-
Lilly and Company's
antipsychotic Zyprexa, and the
other involved Bextra. In the
Bextra case, the
government also
charged Pfizer with
illegally marketing...
- 2017. "Information for
Healthcare Professionals:
Valdecoxib (marketed as
Bextra)". Food and Drug
Administration (FDA).
Archived from the
original on 2 February...
-
Claims Act, FDCA 2009
Pfizer $2.3
billion Off-label promotion,
kickbacks Bextra, Geodon, Zyvox,
Lyrica False Claims Act, FDCA 2013
Johnson &
Johnson $2...
- a
whistleblower in the
investigation of Pfizer's
marketing practices of
Bextra.
Pfizer pleaded guilty to
various civil and
criminal charges and paid in...
